Gossamer Bio Announces Appointment of New Independent Directors

SAN DIEGO–(BUSINESS WIRE)–Gossamer Bio, Inc., a privately held, clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology, today announced the appointment of Joshua H. Bilenker, M.D., Russell J. Cox and Ren?e Gal? to its Board of Directors. Ms. Gal? will also serve as Chair of the Audit Committee. Dr. Bilenker, Mr. Cox and Ms. Gal? will succeed Robert Nelsen and Richard